Collegium Pharmaceutical Inc (COLL) Insider Trading
- $4,316,951.25
- $64,281,832.82
- March 14, 2025
- Michael Thomas Heffernan
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| March 14, 2025 | CFO | 977 | $30.00 | Sell | $29,310.00 | |
| March 14, 2025 | EVP | 2,255 | $30.00 | Sell | $67,650.00 | |
| March 11, 2025 | CFO | 10,445 | $30.01 | Sell | $313,454.45 | |
| March 6, 2025 | EVP | 26,067 | $28.50 | Sell | $742,909.50 | |
| March 6, 2025 | CFO | 1,949 | $30.00 | Sell | $58,470.00 | |
| March 4, 2025 | EVP | 40,000 | $28.08 | Sell | $1,123,200.00 | |
| Jan. 10, 2025 | EVP | 27,500 | $33.04 | Sell | $908,600.00 | |
| Sept. 13, 2024 | EVP | 9,593 | $36.62 | Sell | $351,295.66 | |
| Sept. 5, 2024 | EVP | 19,248 | $38.30 | Sell | $737,198.40 | |
| May 28, 2024 | CFO | 19,710 | $34.21 | Sell | $674,279.10 | |
| May 24, 2024 | EVP | 56,807 | $33.98 | Sell | $1,930,301.86 | |
| May 14, 2024 | Director | 28,985 | $32.30 | Sell | $936,215.50 | |
| Jan. 16, 2024 | EVP | 23,560 | $32.28 | Sell | $760,516.80 | |
| Dec. 21, 2023 | CEO | 4,357 | $30.38 | Sell | $132,365.66 | |
| Dec. 19, 2023 | CEO | 14,516 | $30.03 | Sell | $435,915.48 | |
| Nov. 27, 2023 | EVP | 25,600 | $25.78 | Sell | $659,968.00 | |
| June 26, 2023 | EVP | 17,984 | $21.72 | Sell | $390,612.48 | |
| June 1, 2023 | CEO | 31,272 | $22.09 | Sell | $690,798.48 | |
| May 30, 2023 | CEO | 31,271 | $21.90 | Sell | $684,834.90 | |
| March 15, 2023 | CFO | 31,640 | $23.77 | Sell | $752,082.80 | |
| March 1, 2023 | EVP | 13,324 | $26.70 | Sell | $355,750.80 | |
| Feb. 13, 2023 | EVP | 21,811 | $26.88 | Sell | $586,279.68 | |
| Feb. 13, 2023 | CEO | 11,250 | $26.88 | Sell | $302,400.00 | |
| Jan. 9, 2023 | EVP | 17,834 | $27.39 | Sell | $488,473.26 | |
| Dec. 27, 2022 | Director | 19,815 | $23.73 | Sell | $470,209.95 | |
| Dec. 27, 2022 | CEO | 2,204 | $23.75 | Sell | $52,345.00 | |
| Dec. 23, 2022 | CEO | 147 | $23.00 | Sell | $3,381.00 | |
| Dec. 22, 2022 | Director | 237 | $23.00 | Sell | $5,451.00 | |
| Dec. 21, 2022 | CEO | 7,333 | $23.11 | Sell | $169,465.63 | |
| Dec. 20, 2022 | Director | 33,758 | $23.08 | Sell | $779,134.64 | |
| Dec. 19, 2022 | CEO | 1,134 | $23.01 | Sell | $26,093.34 | |
| Dec. 12, 2022 | Director | 27,920 | $22.01 | Sell | $614,519.20 | |
| Dec. 1, 2022 | CEO | 76,653 | $22.47 | Sell | $1,722,392.91 | |
| Nov. 28, 2022 | CEO | 43 | $22.00 | Sell | $946.00 | |
| Nov. 22, 2022 | CEO | 65 | $22.00 | Sell | $1,430.00 | |
| Nov. 18, 2022 | CEO | 1,989 | $22.02 | Sell | $43,797.78 | |
| Oct. 4, 2022 | CFO | 4,350 | $17.35 | Sell | $75,472.50 | |
| Sept. 15, 2022 | EVP | 38,589 | $18.07 | Sell | $697,303.23 | |
| Aug. 11, 2022 | EVP | 300 | $20.01 | Sell | $6,003.00 | |
| Feb. 18, 2022 | EVP | 10,559 | $21.61 | Sell | $228,179.99 | |
| Dec. 15, 2021 | EVP | 5,693 | $18.33 | Sell | $104,352.69 | |
| May 10, 2021 | EVP | 7,000 | $22.77 | Sell | $159,390.00 | |
| March 15, 2021 | Director | 50,075 | $25.30 | Sell | $1,266,897.50 | |
| March 1, 2021 | Insider | 6,011 | $23.36 | Sell | $140,416.96 | |
| March 1, 2021 | CEO | 64,768 | $22.67 | Sell | $1,468,290.56 | |
| Jan. 20, 2021 | EVP | 6,081 | $24.45 | Sell | $148,680.45 | |
| Jan. 19, 2021 | Insider | 3,324 | $23.00 | Sell | $76,452.00 | |
| Jan. 15, 2021 | EVP | 1,322 | $22.89 | Sell | $30,260.58 | |
| Jan. 12, 2021 | Insider | 7,500 | $21.00 | Sell | $157,500.00 | |
| Jan. 7, 2021 | CTO | 16,042 | $22.00 | Sell | $352,924.00 |
Insiders are both buying and selling Collegium Pharmaceutical Inc stock.
The insider traders at Collegium Pharmaceutical Inc are: Michael Thomas Heffernan, Joseph Ciaffoni, Shirley R Kuhlmann, Scott Dreyer, Alison B Fleming, Colleen Tupper, Paul Brannelly, David Hirsch, Longitude Capital Partners, Ll, Thomas B Smith, John A Fallon, Garen G Bohlin, and John Gordon Freund
The most active insider trader at Collegium Pharmaceutical Inc is Michael Thomas Heffernan with 22 trades.
Longitude Capital Partners, Ll has sold the most Collegium Pharmaceutical Inc stock with a total value of $34,680,000.00.
Longitude Capital Partners, Ll has bought the most Collegium Pharmaceutical Inc stock with a total value of $4,800,000.00.
The most recent insider trade for Collegium Pharmaceutical Inc was on March 14, 2025.
The single biggest insider buy for Collegium Pharmaceutical Inc was from Longitude Capital Partners, Ll with a total value of $2,400,000.00 on May 12, 2015.
The single biggest insider sell for Collegium Pharmaceutical Inc was from Longitude Capital Partners, Ll with a total value of $17,340,000.00 on Dec. 8, 2017.